PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Rosalyn Juergens, MD, PhD - Why Precision Matters in NSCLC: Challenges and Solutions for Targeting Rare Oncogenic Driver Mutations in the Canadian Landscape
Visit https://www.peervoice.com/XVK860 to view the entire programme with slides. After completing “Rosalyn Juergens, MD, PhD - Why Precision Matters in NSCLC: Challenges and Solutions for Targeting Rare Oncogenic Driver Mutations in the Canadian Landscape”, participants will be able to: Discuss the rationale for timely comprehensive genomic profiling in patients with advanced non-small–cell lung cancer (NSCLC); Review expert recommendations to optimize genomic testing in the Canadian healthcare setting; Describe guideline recommendations for the treatment of patients with advanced NSCLC and rare oncogenic driver alterations; and Evaluate the latest evidence with targeted therapies for advanced NSCLC harbouring rare oncogenic driver alterations, with a focus on RET alterations.